Page locked

This page is currently locked for editing by another user. You have to wait until this user finishes editing or the lock expires.

Currently locked by: 216.73.216.28,104.23.243.54
Lock expires at: 2026/10/12 12:45 (9 min)

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

DUPIXENT (raised EOS count required for all)

1. Atopic derm (L20.9 or L20.89) -6 months or older with diagnosis of moderate-to-severe atopic dermatitis -documentation of disease burden (SCORAD, BSA %, EASI, POEM, etc) -inadequate response to potent topical corticosteroids and topical calcineurin inhibitors -inadequate response to oral systemic immunosuppressants or corticosteroids

2. Nasal Polyps (J33.9 or J33.0) -18 years or older with diagnosis of polyps supported by rhinoscopy, endoscopy or CT scan -inadequate response to intranasal and systemic corticosteroids -history of sino-nasal surgery *Depending on insurance, some PA's will ask if med is being prescribed with referral from/ in consultation with ENT provider* -BCBS Federal will only approve Dupixent for Nasal Polyps if ENT prescribing

3. Asthma (J45.40 or J45.50) -6 years or older with diagnosis of moderate-to-severe eosinophilic (EOs > 150 cells/uL) or oral corticosteroid dependent asthma -documentation of 3 months of patient trying asthma treatments -documentation of frequency of hospitalizations, exacerbations, use of rescue therapy

4. EoE (K20.0) -1 year or older & weighs over 15kg -diagnosis of EoE as supported by esophageal biopsy with >15 EOS/HPF -documentation of inadequate response to at least 8 weeks of high dose PPI and 6-8 weeks of oral swallowed steroids like budesonide or fluticasone propionate

PA: Dupixent required through Specialty Pharmacy; not available to buy & bill